NL8501564A - Bepaling voor interferon epsilon. - Google Patents

Bepaling voor interferon epsilon. Download PDF

Info

Publication number
NL8501564A
NL8501564A NL8501564A NL8501564A NL8501564A NL 8501564 A NL8501564 A NL 8501564A NL 8501564 A NL8501564 A NL 8501564A NL 8501564 A NL8501564 A NL 8501564A NL 8501564 A NL8501564 A NL 8501564A
Authority
NL
Netherlands
Prior art keywords
cells
interferon
sample
virus
epsilon
Prior art date
Application number
NL8501564A
Other languages
English (en)
Dutch (nl)
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of NL8501564A publication Critical patent/NL8501564A/nl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL8501564A 1984-07-06 1985-05-31 Bepaling voor interferon epsilon. NL8501564A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/628,612 US4675282A (en) 1984-07-06 1984-07-06 Assay for interferon epsilon
US62861284 1984-07-06

Publications (1)

Publication Number Publication Date
NL8501564A true NL8501564A (nl) 1986-02-03

Family

ID=24519613

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8501564A NL8501564A (nl) 1984-07-06 1985-05-31 Bepaling voor interferon epsilon.

Country Status (14)

Country Link
US (1) US4675282A (fr)
JP (1) JPS6125060A (fr)
AU (1) AU3857085A (fr)
BE (1) BE902663A (fr)
CA (1) CA1244345A (fr)
CH (1) CH666285A5 (fr)
DE (1) DE3515803A1 (fr)
DK (1) DK99185A (fr)
FR (1) FR2567269A1 (fr)
GB (1) GB2161270A (fr)
IT (1) IT1183809B (fr)
NL (1) NL8501564A (fr)
NO (1) NO850536L (fr)
SE (1) SE8500620L (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2642112B2 (ja) * 1986-03-06 1997-08-20 コモンウエルス サイエンテイフイック アンド インダストリアル リサーチ オーガナイゼイシヨン 細胞性免疫応答検出用インビトロ分析
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
CA2311681A1 (fr) 1997-12-08 1999-06-17 Genentech, Inc. Interferon-epsilon humain: interferon de type 1
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
CN103694337B (zh) 2008-02-08 2016-03-02 Ambrx公司 经修饰瘦素多肽和其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1443425A (en) * 1972-10-25 1976-07-21 Searle & Co Interferon assay
US3910824A (en) * 1973-10-18 1975-10-07 Searle & Co Interferon assay
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
NO832517L (no) * 1982-07-12 1984-01-13 Damon Biotech Inc Interferonpreparat, samt fremgangsmaate for dets fremstilling
IL66733A (en) * 1982-09-07 1986-03-31 Yeda Res & Dev Assay for ifn and kit therefor

Also Published As

Publication number Publication date
US4675282A (en) 1987-06-23
FR2567269A1 (fr) 1986-01-10
DK99185D0 (da) 1985-03-04
IT1183809B (it) 1987-10-22
BE902663A (fr) 1985-09-30
CH666285A5 (de) 1988-07-15
SE8500620D0 (sv) 1985-02-12
DK99185A (da) 1986-01-07
JPS6125060A (ja) 1986-02-03
IT8567398A1 (it) 1986-10-30
DE3515803A1 (de) 1986-01-16
IT8567398A0 (it) 1985-04-30
SE8500620L (sv) 1986-01-07
GB2161270A (en) 1986-01-08
CA1244345A (fr) 1988-11-08
NO850536L (no) 1986-01-07
AU3857085A (en) 1986-01-09
GB8517164D0 (en) 1985-08-14

Similar Documents

Publication Publication Date Title
Baker et al. Antiviral immune responses of bats: a review
King et al. Polypeptides of the tail fibres of bacteriophage T4
Abril et al. Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 and 5 in interferon receptor-deficient mice
Naniche et al. Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression
Velazquez-Salinas et al. Increased virulence of an epidemic strain of vesicular stomatitis virus is associated with interference of the innate response in pigs
Carbone et al. Characterization of a glial cell line persistently infected with Borna disease virus (BDV): influence of neurotrophic factors on BDV protein and RNA expression
Finter Quantitative haemadsorption, a new assay technique: I. Assay of interferon
Green et al. Sequential production of IFN-alpha and immune-specific IFN-gamma by human mononuclear leukocytes exposed to herpes simplex virus.
Yeh et al. Automated, quantitative cytopathic effect reduction assay for interferon
John et al. Induction of stress granules by interferon and down-regulation by the cellular RNA adenosine deaminase ADAR1
Van Wyk et al. Induction of functional interferon alpha and gamma responses during acute infection of cattle with non-cytopathic bovine viral diarrhea virus
NL8501564A (nl) Bepaling voor interferon epsilon.
Chen et al. Establishing a safe, rapid, convenient and low-cost antiviral assay of interferon bioactivity based on recombinant VSV expressing GFP
Chantler et al. Replication and expression of rubella virus in human lymphocyte populations
DE69515416T2 (de) Verfahren zum Nachweis von Interferonaktivität
Meager Assays for antiviral activity
Grossberg et al. Assay of interferons
Gates et al. Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry
Cray et al. Serologic diagnosis of sarcocystosis in psittacine birds: 16 cases
Hussain et al. Atopic neutrophils prevent postviral airway disease
Richtsmeier Human interferon production in tonsil and adenoid tissue cultures
Marcus et al. Interferon induction by viruses. XXI. Vesicular stomatitis virus: interferon inducibility as a phylogenetic marker
PITKÄRANTA et al. Virus-induced interferon production in human leukocytes: a low responder to one virus can be a high responder to another virus
Eneroth et al. Interferon‐γ‐Like immunoreactivity in sensory neurons may influence the replication of sendai and mumps viruses
Prince et al. Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed